As previously reported by Melo SA et al. (24), GPC1 was specifically enriched on cancer cell–derived exosomes and showed high specificity over CA-199 or serum-free GPC1 (100% vs 79.49% vs 82.14%) that distinguish noncancer patients from pancreatic cancer patients. The gene discussed is GPC1; the disease is pancreatic neoplasm.